中国医院用药评价与分析2025，Vol.25Issue(2)：223-226,4.DOI:10.14009/j.issn.1672-2124.2025.02.021
17 363条抗肿瘤药物医嘱用药合理性分析
Rationality Analysis on 17 363 Medical Orders of Antitumor Drugs
摘要
Abstract
OBJECTIVE:To investigate the rationality of medical orders of antitumor drugs,so as to promote the rational application of antitumor drugs.METHODS:Retrospective study was carried out to collect 17 363 medical orders of commonly used antitumor drugs from 2021 to 2023 through the Yiyao pre-review system of the hospital,and the irrational medical orders were classified and analyzed.RESULTS:Among 17 363 medical orders of antitumor drugs,407 medical orders were irrational,accounting for 2.34％.The types of irrational medical orders included deficiency of dilution solvent(116 medical orders,28.50％),inappropriate administration route(100 medical orders,24.57％),inappropriate solvent dosage(96 medical orders,23.59％),inappropriate solvent selection(49 medical orders,12.04％),and inappropriate drug dosage(46 medical orders,11.30％).The irrational rate of drug application was decreasing year by year.CONCLUSIONS:The hospital should further standardize the management of antitumor drugs and review of medical orders,strengthen the communication with clinical departments,timely investigate the problems existing in administration and application of antitumor drugs,improve the awareness of standardized application of antitumor drugs by clinicians,decrease the irrational medical orders,and ensure medication safety for patients.关键词
抗肿瘤药物/不合理医嘱/用药分析/处方审核Key words
Antitumor drugs/Irrational medical orders/Medication analysis/Prescription review分类
医药卫生引用本文复制引用
邹思豪,黄雨欣,严丽,王宪英..17 363条抗肿瘤药物医嘱用药合理性分析[J].中国医院用药评价与分析,2025,25(2):223-226,4.基金项目
河北省医学科学研究课题(No.20242192) （No.20242192）
